In this episode, our experts discuss Prime’s four primary tenets of practice for chronic weight management.

Ahead of their session, Jacob and Timothy share how Prime/MRx is working alongside providers like Horizon Blue Cross Blue Shield of New Jersey to manage drug waste and rein in spend for specialty...

One of the Prime Together Foundation’s 2023 grants went to TC Food Justice, which works to reduce food waste and hunger in the Twin Cities by linking those willing to help and those in need.

Integration Solutions Resources Contact The best care is integrated care People feel and live better when care and medicine work together. Integrated drug management helps lower your total cost of...

Integration Solutions Resources Contact Helping to lower drug costs Effective formularies are one of the best ways to ensure you have the lowest total cost of care, and a well-managed formulary...

Report features new highlights and rankings of the top 50 drug classes by percent of net spend.

Certification recognizes quality service and continuous improvement

Notice of privacy practices Effective Date: March 2023 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE...

Develop a holistic GLP-1 strategy An evidence-based approach to GLP-1 drugs helps you implement custom strategies that promote clinically appropriate use and consider affordability, long-term value...

Breadcrumb Home Careers Residency Program Join our residency program The ASHP-accredited Prime Therapeutics PGY1 residency program will allow you to build your best career in managed care. You will...

Help reimagine pharmacy We need the brightest and most passionate people to bring our purpose to life. Search open jobs Breadcrumb Home Careers Work + life in harmony Prime Therapeutics (Prime)...

Grant helps provide a home away from home for families facing cancer

New report, an evolution of previous DEI reports, aims to demonstrate transparency and accountability for company’s corporate social responsibility journey

Prime is committed to simplifying the cancer care journey through leading oncology solutions designed to support people with cancer

The event emphasizes additional measures for obesity therapy.

How Prime Therapeutics/Magellan Rx Management reimagines pharmacy to do what's right.

Our journey to reimagine pharmacy We are fueled by the desire to deliver an intuitive, meaningful, affordable experience that customers and members appreciate. By combining our innovation and...

Report encourages providers to consider health contexts and lifestyle modifications as well as personal preferences and current guidelines when prescribing GLP-1s for weight loss

At Pharmacy Benefit Management Institute (PBMI) annual conference, Prime received two awards: one for cost savings, another for leadership.

Tap into solutions that deliver real value The best Medicare and Managed Medicaid programs are ones that are customized to your needs and member population. Let us put our 40+ years of experience...

Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more

Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies

California Privacy Notice and Policy Prime Therapeutics LLC and all its divisions and subsidiaries (collectively, (“Company”, “Prime”, “we” or “us”) understands the importance of your privacy and...

See our CSR efforts As outlined in our 2023 Corporate Social Responsibility Report, we're committed to creating sustainable social change, rallying around our common purpose. Read the report...

Tap into our Expert Clinical Network Gain insights from leading key opinion leaders (KOLs) to drive better care. Breadcrumb Home Our solutions Specialty drug management Medical pharmacy Expert...

Build healthier communities By delivering affordable, reliable services that help improve health outcomes and coordinate care, we help you get your members the resources they need to live healthier...

Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.

Event features discussions about health care industry trends, best practices and innovations

Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.

Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024

Urick, senior principal health outcomes researcher, shares more about his Spotlight Session at the Academy of Managed Care Pharmacy (AMCP)’s Annual Meeting

JUDI® Client News Your source for JUDI client news and client communications Get a sneak peek into JUDI Watch the latest sneak peek to see JUDI in action and learn more how Prime's exclusive...

Diversity, equity and inclusion Our commitment to diversity, equity and inclusion (DEI) is rooted in our purpose and dedication to serving others. Breadcrumb Home Who we are Diversity, equity and...

Welcome to Mid-Market Central At Prime Therapeutics (Prime), we value our mid-market partner relationships and continually strive to create exceptional experiences for our customers. This resource...

Prime Careers Spotlight: November 2024 Check out our latest job openings. Together, we can help make health care better by helping clients and members navigate pharmacy benefits. Investment...

A look at the specialty landscape and how Prime delivers value to employers

Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...

Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) High Cost Therapy Profile Gene Therapy/Immunology Marnetegragene autotemcel...

Managed Markets Insight & Technology (MMIT)

Ben Urick, senior director of health outcomes, and Landon Marshall, health outcomes research principal, share more about their educational session and research poster on GLP-1s

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.

Read Clinical News: August 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics FDA SAFETY ALERT ON COMPOUNDED...

publications GLP-1 Pipeline Update: November 2024 Quarterly view of the GLP-1 pipeline and anticipated indications November 21, 2024 Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Vice...

publications Quarterly Drug Pipeline: October 2024 Clinical insights and competitive intelligence on anticipated drugs in development October 31, 2025 Editor-in-chief's message Welcome to the Prime...

Quarterly Drug Pipeline: July 2024 Clinical insights and competitive intelligence on anticipated drugs in development Editor-in-chief's message Welcome to the Prime Quarterly Drug Pipeline! Dive...

Quarterly Drug Pipeline: April 2024 Clinical insights and competitive intelligence on anticipated drugs in development Drug Pipeline Clinical insights and competitive intelligence on anticipated...

Quarterly Drug Pipeline: January 2024 Clinical insights and competitive intelligence on anticipated drugs in development Drug Pipeline Clinical insights and competitive intelligence on anticipated...

publications Quarterly Drug Pipeline: January 2025 Clinical insights and competitive intelligence on anticipated drugs in development January 30, 2025 Editor-in-chief's message Welcome to the Prime...

Drug Recalls Tab 1 2025 2024 2023 2022 2021 2020 02/19/2025 - Prograf® (tacrolimus) 0.5 mg and Astagraf XL® (tacrolimus extended-release) 0.5 mg - Astellas About this recall: Astellas is...